A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
NGM Biopharmaceuticals, Inc
Aprea Therapeutics
Stanford University
ADC Therapeutics S.A.
Five Prime Therapeutics, Inc.
pharmaand GmbH
Genmab
Nektar Therapeutics
Incyte Corporation
Pfizer
Incyte Corporation
Incyte Corporation
Eli Lilly and Company
Stanford University
University of Kansas Medical Center
GlaxoSmithKline
Roswell Park Cancer Institute
Amgen
Fox Chase Cancer Center
INSYS Therapeutics Inc
Altor BioScience